Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/170355
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Romero Jódar, Alejandro | - |
dc.contributor.author | Marco-Contelles, José | - |
dc.date.accessioned | 2018-09-28T11:05:21Z | - |
dc.date.available | 2018-09-28T11:05:21Z | - |
dc.date.issued | 2017 | - |
dc.identifier | doi: 10.2174/1568026618666180112155639 | - |
dc.identifier | issn: 1568-0266 | - |
dc.identifier | e-issn: 1873-4294 | - |
dc.identifier.citation | Current Topics in Medicinal Chemistry 17: 3328-3335 (2017) | - |
dc.identifier.uri | http://hdl.handle.net/10261/170355 | - |
dc.description.abstract | Tacrine was the first drug to display beneficial effects on cognitive impairment of Alzheimer Disease (AD) patients. Unfortunately, many treated patients displayed related hepatotoxicity, and hence this drug was withdrawn. Notwithstanding, recent efforts have been directed to design small tacrine analogues targeting the underlying pathogenic mechanisms of AD. In this context, we have developed a number of pyranotacrines by changing the benzene fused ring in tacrine by a 4Hpyran. Based on this strategy, in this account we will show the tacrine analogues that we have designed, synthesized and evaluated as potential multipotent agents for AD in the last years. We have demonstrated that this approach is possible, and that a number of readily available tacrine analogues show cholinesterase inhibition power, as well as other pharmacological properties, such as calcium channel blockade, antioxidant properties, neuroprotection, Aβ-amyloid inhibition aggregation capacity, etc., making them suitable multipotent molecules for further development for the potential treatment of AD. | - |
dc.description.sponsorship | JMC thanks all the co-workers, whose names and contributions have been shown in the review, for their dedication and commitment with this project. Without their help, this project would never have progressed, and could not have been carried out. | - |
dc.publisher | Bentham Science Publishers | - |
dc.rights | closedAccess | - |
dc.subject | Multi-Target-Directed Ligands | - |
dc.subject | Alzheimer’s disease | - |
dc.subject | Neuroprotection | - |
dc.subject | Butyrylcholinesterase inhibitors | - |
dc.subject | Acetylcholinesterase inhibitors | - |
dc.subject | Pyranotacrines | - |
dc.subject | Tacrine | - |
dc.title | Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines | - |
dc.type | artículo | - |
dc.identifier.doi | 10.2174/1568026618666180112155639 | - |
dc.relation.publisherversion | http://dx.doi.org/10.2174/1568026618666180112155639 | - |
dc.date.updated | 2018-09-28T11:05:21Z | - |
dc.description.version | Peer Reviewed | - |
dc.language.rfc3066 | eng | - |
dc.relation.csic | Sí | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
Aparece en las colecciones: | (IQM) Artículos (IQOG) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
13
checked on 31-mar-2024
WEB OF SCIENCETM
Citations
12
checked on 27-feb-2024
Page view(s)
313
checked on 19-abr-2024
Download(s)
97
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.